Navigation Links
New Bisphenol A Study Is of Very Limited Relevance to Human Health
Date:6/17/2009

ARLINGTON, Va., June 17 /PRNewswire-USNewswire/ -- The following statement can be attributed to Steven G. Hentges, Ph.D. of the American Chemistry Council's (ACC) Polycarbonate/BPA Global Group. Dr. Hentges' comments are in regard to a study from researchers at North Carolina State University (NCSU) and the National Institute of Environmental Health Sciences (NIEHS). The study, "Neonatal bisphenol A exposure alters rat reproductive development and ovarian morphology without impairing activation of gonadotropin releasing hormone neurons," was funded by NIEHS and published online June 17 by the journal Biology of Reproduction. The study was co-authored by Heather B. Patisaul and Heather B. Adewale of NCSU and Wendy N. Jefferson and Retha R. Newbold of NIEHS.

"The American Chemistry Council (ACC) and its member companies have long-supported research to advance scientific understanding about chemicals and promote public health. To achieve these goals with limited resources, including limited use of laboratory animals, study designs should be based on sound scientific principles and data so as to be directly relevant to human health. This new study fails to meet these basic study design principles and practices.

"It is a continuing disappointment to see that researchers -- including scientists from National Institute of Environmental Health Sciences (NIEHS) -- conduct studies that involve injection of laboratory animals with bisphenol A (BPA). This experimental technique has recently been acknowledged by the NIEHS to have very limited value for assessing human health effects since people are orally exposed to BPA, not by injection. It is well-known that BPA is efficiently metabolized and rapidly eliminated from the body after oral exposure.

"The researchers also state, incorrectly, that their study is significant because it used a dose equal to the EPA reference dose for BPA, which is a science-
'/>"/>

SOURCE American Chemistry Council
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Bisphenol A Study Has Limited Capability to Assess Human Health Effects
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
8. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
9. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
10. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
11. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... July 7, 2015 Noting the need to ... policies currently practiced by the rapidly consolidating pharmacy benefit ... today praised Ohio Governor ... new state effort to help pull back the curtain ... "We applaud Governor Kasich for bringing badly-needed reform ...
(Date:7/7/2015)... 7, 2015  Dedicated to promoting wellness and giving ... took the purple pledge in support of Alzheimer,s ... Brain-Awareness Month, a time to shine a purple light ... all the people in our community who are affected ... the disease, and helps mobilize friends, family members, neighbors ...
(Date:7/7/2015)... and BANGALORE , July ... a global technology provider of innovative clinical trial data ... (Industry Standard Research Reports) recent publication named " EDC ... Performance (2015) ". ISR Reports is one of the ... industry, and this report evaluated 22 EDC and eCOA ...
Breaking Medicine Technology:National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 2National LTC Pharmacy Leader Praises Kasich Effort to Bring Transparency to PBM Drug Pricing 3Purple for a Purpose: Supporting Alzheimer's & Brain-Awareness Month 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
... D-Pharm announced today the,completion of a financial round, which ... late stage clinical stroke program. The,financial round combined a rights ... of NIS 28 million. The IPO was oversubscribed and the,unit ... minimum price. The,company,s pre-money valuation was NIS 120 million. , ...
... , , , ... Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a ... patients manage this devastating disease. , , Extavia ... MS to reduce the frequency of clinical exacerbations. The therapy is also ...
Cached Medicine Technology:D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 2D-Pharm Raises NIS 85 Million in Rights Offering and Initial Public Offering (IPO) on the Tel Aviv Stock Exchange (TASE) 3US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 2US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 3US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 5US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 6US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 7
(Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency Foundation ... patient community using its IDF ePHR, an electronic personal health record powered by ... to easily track their health information, including symptoms, diagnoses, medications, infusions and other ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... Downtown Detroit was the site of the National Baptist Convention 110th Annual Session ... on encouraging and promoting the collaboration of churches and their congregations, medical professionals ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Dr. ... on teeth whitening treatments. A professional teeth whitening is one of the fastest, easiest ... as well as they can decrease smile satisfaction and confidence. With the right teeth ...
(Date:7/7/2015)... ... July 07, 2015 , ... Office Practicum announced today ... Chief Financial Officer, effective July 6th, 2015. Ellen joins Office Practicum with more ... multi-billion dollar, global chemical company to early and growth-stage technology companies. , ...
(Date:7/7/2015)... Schaumburg, IL (PRWEB) , ... ... ... Solutions, Inc., a leading provider of unified communication management solutions, has announced ... Solution, Infortel® Select. , This service pack includes a number of enhancements ...
Breaking Medicine News(10 mins):Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 2Health News:A Forever Recovery CEO Per Wickstrom Speaks to Audience at National Baptist Convention's 11th Annual Health Fair 3Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 2Health News:Los Angeles Cosmetic Dentist, Poneh Ghasri DDS, Now Offers Promotions on Whitening Treatments 3Health News:Office Practicum Announces new CFO 2Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2
... ... that will allow urgent care facilities to publish wait time information to their ... facility when it’s not as busy. Otherwise, they can access UrgentCareLocator.com and ... time. Also, an iPhone application will be released that will provide the ...
... ... Free Webinars Announced From ERISAclaim.com To Discuss The Latest And The First ... Lawsuit Against Anthem BCBS, For The Alleged Wrongful Overpayment Recoupment and Even ... Than PPO Contracts And State Laws. The Court Decision Was Mainly Relied ...
... ... Richard Gurfein, regarded as one of the best medical malpractice attorneys in ... Lawyers Association, urges cancer patients to talk to their doctor about the ... offers patients helpful tips on how to evaluate the treatment they are ...
... children with cancer enrolled in therapeutic clinical research trials shows ... them about their participation, nor do they feel they are ... study, led by Yoram Unguru, M.D., an associate faculty member ... published online March 29 in the journal Pediatrics . ...
... Boston have identified a new strategy for treating type ... people become obese. By activating this pathway artificially, they ... obese and diabetic mice. Their findings will be published ... Epidemiologists have long known that obesity contributes to ...
... ... ... years of first responders bearing not only the responsibility of preserving the peace and saving ... of police lights and light bars at an affordable price. With a fully ...
Cached Medicine News:Health News:Urgent Care Wait Times Will Be Posted On the Web and Available From an iPhone 2Health News:New Free Webinars Announced to Discuss the Latest Federal Court Overpayment Lawsuit Ruling and New Obama Health Laws for the Skyrocketing $6 Trillion Overpayment Recoupment Market 2Health News:New Free Webinars Announced to Discuss the Latest Federal Court Overpayment Lawsuit Ruling and New Obama Health Laws for the Skyrocketing $6 Trillion Overpayment Recoupment Market 3Health News:New Free Webinars Announced to Discuss the Latest Federal Court Overpayment Lawsuit Ruling and New Obama Health Laws for the Skyrocketing $6 Trillion Overpayment Recoupment Market 4Health News:New York Medical Malpractice Attorney Recommends Cancer Patients Take Precautionary Steps Before Undergoing Radiation Therapy 2Health News:New York Medical Malpractice Attorney Recommends Cancer Patients Take Precautionary Steps Before Undergoing Radiation Therapy 3Health News:Childhood cancer patients enrolled in clinical trials need clearer communication about their role 2Health News:Childhood cancer patients enrolled in clinical trials need clearer communication about their role 3Health News:A new strategy normalizes blood sugars in diabetes 2Health News:High Quality Strobe Lights and Light Bars at an Affordable Price 2
19 gauge x 8 mm with 15 cm high pressure extension tube preattached to a 10C ring control syringe. 3 per box....
Angled, 20 gauge x 25 mm cannula with 30 gauge x 5 mm tip. 30 gauge cannula extends into hub 2 mm from end of hub, angled 45 degrees 2.5 mm from tip. 10 per box....
The moist air humidifying chamber is designed for the infusion of humidified air during phakic fluid air exchange. Sterile single-use. 10 per box. Most popular size or model....
Includes one aluminum Fox eye shield and one eye Garter shield cover. Packaged 50 per box. White only....
Medicine Products: